Envoy Medical (COCH) Income from Continuing Operations (2021 - 2026)
Envoy Medical's (COCH) quarterly Income from Continuing Operations came in at -$5.6 million in Q2 2026, up 2.2% year-over-year from -$5.4 million in Q2 2025, and up 6.54% quarter-over-quarter from -$6.0 million in Q1 2026.
Powered by 
Analysis
Envoy Medical (COCH) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Envoy Medical has disclosed Income from Continuing Operations across 6 years of filings, most recently posting -$5.6 million for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 2.2% year-over-year to -$5.6 million; the TTM figure through Jun 2026 stood at -$24.1 million (down 12.24% YoY), while the FY2025 annual figure was -$23.9 million, down 18.87% from the prior year.
- Income from Continuing Operations came in at -$5.6 million for Q2 2026 at Envoy Medical, up from -$6.0 million in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of $12.5 million in Q1 2022 to a low of -$6.7 million in Q4 2023.
- Average Income from Continuing Operations over 5 years is -$2.6 million, with a median of -$5.0 million recorded in 2024.
- Year-over-year, Income from Continuing Operations surged 1400.18% in 2022 and sank 785.52% in 2024.
- Over 5 years, Income from Continuing Operations stood at -$2.0 million in 2022, then sank by 234.69% to -$6.7 million in 2023, then increased by 26.63% to -$4.9 million in 2024, then decreased by 29.43% to -$6.4 million in 2025, then gained by 12.78% to -$5.6 million in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were -$5.6 million in Q2 2026, -$6.0 million in Q1 2026, and -$6.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Envoy Medical | 72.94 Mn | 53.26 Mn | -227,000.00 | -5.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.57 Mn |
| Mar 31, 2026 | -5.96 Mn |
| Dec 31, 2025 | -6.39 Mn |
| Sep 30, 2025 | -6.18 Mn |
| Jun 30, 2025 | -5.69 Mn |
| Mar 31, 2025 | -5.60 Mn |
| Dec 31, 2024 | -4.93 Mn |
| Sep 30, 2024 | -5.24 Mn |
| Jun 30, 2024 | -4.98 Mn |
| Mar 31, 2024 | -4.92 Mn |
| Dec 31, 2023 | -6.72 Mn |
| Sep 30, 2023 | -3.39 Mn |
| Jun 30, 2023 | -1.14 Mn |
| Mar 31, 2023 | 717,701.00 |
| Dec 31, 2022 | -2.01 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | 3.09 Mn |
| Mar 31, 2022 | 12.46 Mn |
| Dec 31, 2021 | -4.72 Mn |
| Sep 30, 2021 | 5.57 Mn |